Cargando…
Airway Smooth Muscle–Specific Transcriptomic Signatures of Glucocorticoid Exposure
Glucocorticoids, commonly used asthma controller medications, decrease symptoms in most patients, but some remain symptomatic despite high-dose treatment. The physiological basis underlying the glucocorticoid response, especially in asthma patients with severe, refractory disease, is not fully under...
Autores principales: | Kan, Mengyuan, Koziol-White, Cynthia, Shumyatcher, Maya, Johnson, Martin, Jester, William, Panettieri, Reynold A., Himes, Blanca E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604213/ https://www.ncbi.nlm.nih.gov/pubmed/30694689 http://dx.doi.org/10.1165/rcmb.2018-0385OC |
Ejemplares similares
-
CEBPD modulates the airway smooth muscle transcriptomic response to glucocorticoids
por: Kan, Mengyuan, et al.
Publicado: (2022) -
Vitamin D Modulates Expression of the Airway Smooth Muscle Transcriptome in Fatal Asthma
por: Himes, Blanca E., et al.
Publicado: (2015) -
Epinephrine evokes shortening of human airway smooth muscle cells following β(2) adrenergic receptor desensitization
por: Deeney, Brian T., et al.
Publicado: (2022) -
RNA-Seq Transcriptome Profiling Identifies CRISPLD2 as a Glucocorticoid Responsive Gene that Modulates Cytokine Function in Airway Smooth Muscle Cells
por: Himes, Blanca E., et al.
Publicado: (2014) -
Using omics approaches to understand pulmonary diseases
por: Kan, Mengyuan, et al.
Publicado: (2017)